CTI BIOPHARMA CORP reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Seattle, WA
SEC filing record 1 source field available
Fiscal year end
31 December
CTI BIOPHARMA CORP has filed 2,393 SEC EDGAR filings since 27 Jun 1996

SEC filing history

Showing 151-175 of 1,000 matching filings.

Per page
25
Current page
7
4

PRIMARY DOCUMENT

Filing date
26 Jan 2023
Reporting date
24 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
26 Jan 2023
Reporting date
24 Jan 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-48459

SC 13G/A filing

Filing date
09 Jan 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jan 2023
Reporting date
29 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Jan 2023
Reporting date
29 Dec 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Nov 2022
Reporting date
09 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Nov 2022
Reporting date
08 Nov 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-48459

SC 13G filing

Filing date
11 Oct 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Oct 2022
Reporting date
04 Oct 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Oct 2022
Reporting date
29 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Sep 2022
Reporting date
30 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Sep 2022
Reporting date
12 Sep 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-266926

EFFECT filing

Filing date
25 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
23 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
19 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-266926

S-3

Filing date
17 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Aug 2022
Reporting date
16 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
11 Aug 2022
Reporting date
09 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-48459

AMENDMENT NO. 8 TO THE SCHEDULE 13D

Filing date
11 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .